Hirschsprung's disease (HD) is one of the commonest gastrointestinal m
alformations, as it affects one child out of 5.000 births. It classica
lly induces severe neonatal intestinal obstruction requiring surgical
treatment which currently ensures a favourable prognosis for most of t
he affected children. Although the great majority of cases are sporadi
c, the existence of familial forms (10% of cases) has allowed localiza
tion and then identification of an autosomal dominant gene on chromoso
me 10, the RET proto-oncogene, responsible for 50% of familial forms a
nd 15% of sporadic cases. A second gene has been recently localized on
chromosome 13, the endothelin beta receptor (EDNRB) gene. Two homozyg
ous mutations of the EDNRB gene have been identified in two consanguin
eous families, in which HD is associated with Waardenburg's syndrome (
WS). Other heterozygous mutations have been identified in patients pre
senting with isolated HD and an 5% of cases of HD can be considered to
present mutations of this gene. Finally, the authors have recently id
entified a mutation of the endothelin gene 3 (EDN3), one of the EDNRB
ligands in a patient presenting with a combination of HD and WS. This
mutation, present at the homozygous state in this patient, is predicti
ve of complete absence of EDN3 protein: this is therefore the third kn
own gene responsible for HD.